FI902882A0 - Menetelmä terapeuttisesti aktiivisten 4-/4-/4-/4-/2-(2,4-difluorifenyyli)-2-(1H-atsolyylimetyyli)-1,3-dioksolan-4-yyli/metoksi/fenyyli/-1-piperatsinyyli/fenyylisubstituoitujen triatsolonien ja imidatsolonien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten 4-/4-/4-/4-/2-(2,4-difluorifenyyli)-2-(1H-atsolyylimetyyli)-1,3-dioksolan-4-yyli/metoksi/fenyyli/-1-piperatsinyyli/fenyylisubstituoitujen triatsolonien ja imidatsolonien valmistamiseksi

Info

Publication number
FI902882A0
FI902882A0 FI902882A FI902882A FI902882A0 FI 902882 A0 FI902882 A0 FI 902882A0 FI 902882 A FI902882 A FI 902882A FI 902882 A FI902882 A FI 902882A FI 902882 A0 FI902882 A0 FI 902882A0
Authority
FI
Finland
Prior art keywords
azolylmethyl
triazolones
imidazolones
dioxolan
difluorophenyl
Prior art date
Application number
FI902882A
Other languages
English (en)
Swedish (sv)
Other versions
FI96031B (fi
FI96031C (fi
Inventor
Jan Heeres
Leo Jacobus Jozef Backx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI902882A0 publication Critical patent/FI902882A0/fi
Publication of FI96031B publication Critical patent/FI96031B/fi
Application granted granted Critical
Publication of FI96031C publication Critical patent/FI96031C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI902882A 1989-06-09 1990-06-08 Menetelmä terapeuttisesti aktiivisten 4-/4-/4-/4-/2-(2,4-difluorifenyyli)-2-(1H-atsolyylimetyyli)-1,3-dioksolan-4-yyli/metoksi/fenyyli/-1-piperatsinyyli/fenyylisubstituoitujen triatsolonien ja imidatsolonien valmistamiseksi FI96031C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36379589A 1989-06-09 1989-06-09
US36379589 1989-06-09

Publications (3)

Publication Number Publication Date
FI902882A0 true FI902882A0 (fi) 1990-06-08
FI96031B FI96031B (fi) 1996-01-15
FI96031C FI96031C (fi) 1996-04-25

Family

ID=23431765

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902882A FI96031C (fi) 1989-06-09 1990-06-08 Menetelmä terapeuttisesti aktiivisten 4-/4-/4-/4-/2-(2,4-difluorifenyyli)-2-(1H-atsolyylimetyyli)-1,3-dioksolan-4-yyli/metoksi/fenyyli/-1-piperatsinyyli/fenyylisubstituoitujen triatsolonien ja imidatsolonien valmistamiseksi

Country Status (20)

Country Link
EP (1) EP0402989B1 (fi)
JP (1) JP2988689B2 (fi)
KR (1) KR0163034B1 (fi)
CN (1) CN1025193C (fi)
AT (1) ATE136305T1 (fi)
AU (1) AU624515B2 (fi)
CA (1) CA2018442C (fi)
DE (1) DE69026311T2 (fi)
DK (1) DK0402989T3 (fi)
ES (1) ES2087886T3 (fi)
FI (1) FI96031C (fi)
GR (1) GR3019686T3 (fi)
HU (1) HU215602B (fi)
IE (1) IE71196B1 (fi)
IL (1) IL94660A (fi)
NO (1) NO175477C (fi)
NZ (1) NZ233502A (fi)
PT (1) PT94320B (fi)
RU (1) RU2056421C1 (fi)
ZA (1) ZA904458B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
SK94393A3 (en) * 1992-09-11 1994-08-10 Thomae Gmbh Dr K Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
US5486625A (en) * 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
TW593312B (en) * 1997-07-11 2004-06-21 Janssen Pharmaceutica Nv 2,4,4-trisubstituted-1,3-dioxolane antifungals
KR100342383B1 (ko) * 1999-06-17 2002-12-06 한국화학연구원 이소옥사졸리딘 유도체, 그의 제조 방법 및 그를 포함하는 살균제 조성물
EP2112228A1 (en) * 1999-07-28 2009-10-28 Kaken Pharmaceutical Co., Ltd. Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
CN1706834B (zh) * 2004-06-11 2010-04-28 横店集团成都分子实验室有限公司 具抗真菌活性的三唑醇类新衍生物及制备方法和医药用途
CN102234267A (zh) * 2010-04-21 2011-11-09 中国科学院上海药物研究所 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途
CN106146480B (zh) * 2016-07-18 2019-08-06 山东罗欣药业集团恒欣药业有限公司 一种伊曲康唑的制备方法
CN107455342B (zh) * 2017-08-22 2020-03-10 沧州市农林科学院 三唑酮在提高资源昆虫成活率和/或体重中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions

Also Published As

Publication number Publication date
RU2056421C1 (ru) 1996-03-20
EP0402989A2 (en) 1990-12-19
EP0402989B1 (en) 1996-04-03
EP0402989A3 (en) 1992-01-02
HU215602B (hu) 1999-01-28
FI96031B (fi) 1996-01-15
GR3019686T3 (en) 1996-07-31
AU624515B2 (en) 1992-06-11
ES2087886T3 (es) 1996-08-01
HU903767D0 (en) 1990-11-28
KR0163034B1 (ko) 1998-12-01
AU5689490A (en) 1990-12-13
ZA904458B (en) 1992-02-26
NO175477B (no) 1994-07-11
FI96031C (fi) 1996-04-25
IE71196B1 (en) 1997-02-12
CA2018442A1 (en) 1990-12-09
HUT58325A (en) 1992-02-28
CN1047865A (zh) 1990-12-19
IE902072L (en) 1990-12-09
PT94320B (pt) 1996-12-31
NO902553L (no) 1990-12-10
CA2018442C (en) 2002-02-12
JPH03163077A (ja) 1991-07-15
PT94320A (pt) 1991-02-08
NZ233502A (en) 1991-11-26
JP2988689B2 (ja) 1999-12-13
NO902553D0 (no) 1990-06-08
CN1025193C (zh) 1994-06-29
KR910000714A (ko) 1991-01-30
DK0402989T3 (da) 1996-05-06
DE69026311D1 (de) 1996-05-09
IL94660A (en) 1995-07-31
IL94660A0 (en) 1991-04-15
DE69026311T2 (de) 1996-09-05
NO175477C (no) 1994-10-19
ATE136305T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
FI881404A0 (fi) Framstaellning av 4-/4-/4-/4-//2-(2,4 -difluorfenyl)-2-(1h-azolylmetyl)-1,3-dioxolan-4-yl/metoxi/fenyl/ -1-piperazinyl/fenyl/triazoloner.
FI865257A0 (fi) Derivat av nya //4-/4-(4-fenyl -piperazinyl) fenoximetyl/-1,3-dioxolan-2-yl/metyl-1h-imidazoler och 1h-1,2,4-triazoler.
FI96031B (fi) Menetelmä terapeuttisesti aktiivisten 4-/4-/4-/4-/2-(2,4-difluorifenyyli)-2-(1H-atsolyylimetyyli)-1,3-dioksolan-4-yyli/metoksi/fenyyli/-1-piperatsinyyli/fenyylisubstituoitujen triatsolonien ja imidatsolonien valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: JANSSEN PHARMACEUTICA N.V.